Abstract
The 1,2,4-triazoles are an important group of medicinal substances which exhibit a wide range of activity, such as analgesic, antibacterial, fungicidal, antinflammatory, antiviral and anticancer. As a part of our long-term study on 1,2,4- triazoles we synthesize 4-benzyl-3-[(1-methylpyrrol-2-yl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one which is characterized with anticancer activity. Here, we present an exhaustive studies of its electronic and molecular structure, aimed to rationalize the observed pharmacological activity, supported by the molecular docking to the EGFR kinase domain ATP binding site. The structural studies include X-ray analysis, experimental and computed spectral analysis (1H and 13C NMR, IR) as well as conformational analysis and the frontal molecular orbitals (FMO) analysis. The results of molecular docking indicate that interaction of 4-benzyl-3-[(1-methylpyrrol-2-yl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one with the EGFR kinase domain ATP binding site may be responsible for the observed anticancer activity of this 1,2,4-triazole derivative. Moreover, we find that formation of the respective ligand-protein complex is conditioned by the keto-enol tautomerism of the ligand, i.e. the energetic prevalence of the keto form.
Keywords: B3LYP DFT, Conformational analysis, EGFR, Hartree-Fock, Keto-enol tautomerism, Receptor tyrosine kinases, 1, 2, 4-triazol-5-one, insecticides, antioxidant, keto-enol
Medicinal Chemistry
Title:Structural and Molecular Docking Studies of 4-Benzyl-3-[(1-methylpyrrol- 2-yl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one with Anticancer Activity
Volume: 9 Issue: 3
Author(s): Agnieszka A. Kaczor, Monika Pitucha, Zbigniew Karczmarzyk, Waldemar Wysocki, Jolanta Rzymowska and Dariusz Matosiuk
Affiliation:
Keywords: B3LYP DFT, Conformational analysis, EGFR, Hartree-Fock, Keto-enol tautomerism, Receptor tyrosine kinases, 1, 2, 4-triazol-5-one, insecticides, antioxidant, keto-enol
Abstract: The 1,2,4-triazoles are an important group of medicinal substances which exhibit a wide range of activity, such as analgesic, antibacterial, fungicidal, antinflammatory, antiviral and anticancer. As a part of our long-term study on 1,2,4- triazoles we synthesize 4-benzyl-3-[(1-methylpyrrol-2-yl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one which is characterized with anticancer activity. Here, we present an exhaustive studies of its electronic and molecular structure, aimed to rationalize the observed pharmacological activity, supported by the molecular docking to the EGFR kinase domain ATP binding site. The structural studies include X-ray analysis, experimental and computed spectral analysis (1H and 13C NMR, IR) as well as conformational analysis and the frontal molecular orbitals (FMO) analysis. The results of molecular docking indicate that interaction of 4-benzyl-3-[(1-methylpyrrol-2-yl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one with the EGFR kinase domain ATP binding site may be responsible for the observed anticancer activity of this 1,2,4-triazole derivative. Moreover, we find that formation of the respective ligand-protein complex is conditioned by the keto-enol tautomerism of the ligand, i.e. the energetic prevalence of the keto form.
Export Options
About this article
Cite this article as:
A. Kaczor Agnieszka, Pitucha Monika, Karczmarzyk Zbigniew, Wysocki Waldemar, Rzymowska Jolanta and Matosiuk Dariusz, Structural and Molecular Docking Studies of 4-Benzyl-3-[(1-methylpyrrol- 2-yl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one with Anticancer Activity, Medicinal Chemistry 2013; 9 (3) . https://dx.doi.org/10.2174/1573406411309030002
DOI https://dx.doi.org/10.2174/1573406411309030002 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Natural Product Gossypol and its Derivatives in Precision Cancer Medicine
Current Medicinal Chemistry Magnetic Nanoparticles for MRI of Brain Tumors
Current Pharmaceutical Biotechnology Advances Towards The Discovery of GPR55 Ligands
Current Medicinal Chemistry Py-GC/MS as a Powerful and Rapid Tool for Determining Lignin Compositional and Structural Changes in Biological Processes
Current Analytical Chemistry Indazole and its Derivatives in Cardiovascular Diseases: Overview, Current Scenario, and Future Perspectives
Current Topics in Medicinal Chemistry Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective
Current Pharmaceutical Design Cell Penetrating Peptide Delivery of Splice Directing Oligonucleotides as a Treatment for Duchenne Muscular Dystrophy
Current Pharmaceutical Design Neem-Borne Molecules as Eco-Friendly Control Tools Against Mosquito Vectors of Economic Importance
Current Organic Chemistry Recent Advances in Raman Analysis of Plants: Alkaloids, Carotenoids, and Polyacetylenes
Current Analytical Chemistry Radionuclide Therapy of Cancer with Radiolabeled Antibodies
Anti-Cancer Agents in Medicinal Chemistry Honey as a Source of Dietary Antioxidants: Structures, Bioavailability and Evidence of Protective Effects Against Human Chronic Diseases
Current Medicinal Chemistry Molecular Basis of the Anti-Inflammatory Effects of Terpenoids
Inflammation & Allergy - Drug Targets (Discontinued) Inhibition of Disulfide Reductases as a Therapeutic Strategy
Current Enzyme Inhibition On the Search for Skin Gene Therapy Strategies of Xeroderma Pigmentosum Disease
Current Gene Therapy Bergenin - A Biologically Active Scaffold: Nanotechnological Perspectives
Current Topics in Medicinal Chemistry Ion Transporters in Brain Tumors
Current Medicinal Chemistry Etanercept Improves Cognitive Performance and Increases eNOS and BDNF Expression During Experimental Vascular Dementia in Streptozotocin- induced Diabetes
Current Neurovascular Research Blood-Brain Barrier Changes in High Altitude
CNS & Neurological Disorders - Drug Targets Vitamin D Therapy in Cardiac Hypertrophy and Heart Failure
Current Pharmaceutical Design Drug Repurposing in the Development of Anticancer Agents
Current Medicinal Chemistry